Cancer Genetics, Inc. Receives New York State Licensure for FHACT Cervical Cancer Test

By: via Benzinga
Cancer Genetics, Inc. (Nasdaq: CGIX) ("CGI" or "The Company"), an emerging leader in DNA-based cancer diagnostics, announced today that ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.